Prosecution Insights
Last updated: April 19, 2026

Y-Mabs Therapeutics Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18008581 CD38 antibodies for the treatment of human diseases SUNSHINE, HANNAH LOUISE 1647 Non-Final OA Dec 06, 2022
17924161 Anti-B7H3 Antibodies for the Treatment of Cancer SWARTWOUT, BRIANNA KENDALL 1644 Non-Final OA Nov 09, 2022

Managing Y-Mabs Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month